Clinical Trials Logo

Brain Damage, Chronic clinical trials

View clinical trials related to Brain Damage, Chronic.

Filter by:
  • None
  • Page 1

NCT ID: NCT04928534 Recruiting - Clinical trials for Chronic Traumatic Encephalopathy

Cohort Study of Blood Biomarkers for TES

Start date: May 1, 2021
Phase:
Study type: Observational

In this study, high-throughput screening and multi-omics (transcriptomics and proteomics) joint analysis technology will be employed to explore potential CTE/TES biomarkers (RNA and protein) in blood and its exosomes. Thereafter, these biomarkers will be combined with the reported TBI biomarkers to create a novel set of CTE/TES molecular diagnostic signatures. The findings may open a new avenue for the clinical diagnosis of the disease and the future research on its therapeutic strategy.

NCT ID: NCT04903015 Recruiting - Clinical trials for Traumatic Chronic Encephalopathy

Cerebral and Cognitive Impact of Professional Soccer Practice

TC-FOOT
Start date: January 7, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate, using MRI, the microstructural consequences and the onset of any cognitive impairment in professional soccer players at the end of their career, who have experienced repeated minor head injuries. Over the long term, these head injuries could lead to morphological lesions and have an impact on soccer players' cognitive skills. The main evaluation criterion corresponds to the modifications found on MRI in the professional soccer player group (diffusion tensor, cerebral perfusion, fMRI, cerebral volumetry and cortical thickness, spectroscopy, susceptibility imaging). This is an exposure/nonexposure study assessing the onset of MRI abnormalities (diffusion tensor, cerebral perfusion, fMRI, volumetry and cortical thickness, spectroscopy, susceptibility imaging) in professional soccer players exposed to repeated mild head injuries, who are either at the end of their career or retired for approximately 10 years, compared to high-level athletes not exposed to head injuries.

NCT ID: NCT04118491 Withdrawn - Clinical trials for Carbon Monoxide Poisoning

Hyperbaric Oxygen for Carbon Monoxide Induced Chronic Encephalopathy

HACMICE
Start date: July 2020
Phase: N/A
Study type: Interventional

In some patients, a few days or weeks after recovery from carbon monoxide poisoning, new symptoms develop. These can affect mood, ability to think or remember clearly, and movements. Some people develop movement problems that are similar to Parkinson's disease. This damage to brain tissue is called "encephalopathy," and this study will look at the effect of pressurized oxygen therapy on long term, or chronic, encephalopathy.

NCT ID: NCT03625570 Completed - Cerebral Palsy Clinical Trials

Power Training Combined With Interval Treadmill Training

PT³
Start date: April 15, 2019
Phase: N/A
Study type: Interventional

Ambulatory children with cerebral palsy (CP) experience walking limitations which negatively influence their ability to physically participate in day to day life. The investigators propose that impaired muscle power generation is the key limiting factor affecting walking activity and participation. This proposal represents a combined approach where participants undergo resistance training for muscle power generation in combination with locomotor treadmill training that is based on typical pediatric walking and activity patterns rather than adult protocols, which are endurance or time-based. Therefore, the primary objective of this randomized controlled trial is to determine the effect of lower extremity Power Training combined with interval Treadmill Training (PT³) on functional walking capacity and community-based activity and participation in children with CP. We hypothesize that remediating the most pronounced muscle performance impairment (i.e., muscle power) with power training combined with a task- specific approach to walking that is developmentally appropriate will have a significant effect on walking capacity and performance.

NCT ID: NCT02959294 Withdrawn - Concussion, Brain Clinical Trials

Use of Adipose-Derived Stem/Stromal Cells in Concussion and Traumatic Brain Injuries

C-TBI
Start date: November 30, 2018
Phase: Early Phase 1
Study type: Interventional

Concussion is the most common type of brain injury throughout life. Study is seeking improvement of long-term residua following adolescent and adult post-traumatic injuries often associated with contact sports and accidental causes. Typically defined as reversible head injury with temporary loss of brain function. Symptoms range from physical, cognitive, pain (headache) and emotional signs consistent with TBI and Post-Traumatic Stress Syndrome. Use of AD-cSVF parenteral delivery to encourage repair of damage and decreased function following concussion, particularly in contact, repetitive sports injuries. Range of damage is measured in Grade I-III according to graduated severity. Unfortunately, less information is available about repetitive concussions and the long-term health issues.

NCT ID: NCT02810626 Not yet recruiting - Clinical trials for Brain Damage, Chronic

DTI & Tractography in Pediatric Tumor Surgery

Start date: July 2016
Phase: N/A
Study type: Interventional

The goal of this project will be to demonstrate that Synaptive Medical's Diffusion Tensor Imaging(DTI) product functionality used in pre-operative planning and intraoperative surgical navigation, improves clinical outcomes corresponding to a reduction in neurological and neuropsychological deficits in pediatric brain tumor surgery.

NCT ID: NCT02637817 Recruiting - Cerebral Palsy Clinical Trials

MRI-based Biomarkers for Predicting Punctate White Matter Lesions in Neonates

PWML
Start date: January 2016
Phase:
Study type: Observational

As a common white matter (WM) disease in preterm neonates, punctate white matter lesion (PWML) frequently leads to the abnormalities of brain development (e.g. the motor, visual and auditory disorders), even to cerebral palsy (CP) and amblyopia during childhood. However, it is lack of certain methods in identifying the prognosis of PWML. Through using various advanced MRI techniques, neuro-behavioral and visual assessments, a multicenter longitudinal study would be conducted to follow-up the PWML neonates with varying spatial-position and degree lesions. Through tracking the variations in WM microstructures from neonate period to childhood (2 years old and 3 years old), this study aims to explore (1) the potential relations between varying PWMLs and motor and visual disorders (2) the relations between WM MRI-metrics and neurodevelopmental assessment results, and thus determine the early biomarkers to identify CP and amblyopia.

NCT ID: NCT01602276 Terminated - Clinical trials for Brain Damage, Chronic

The Effect of tDCS on Subcortical Brain Functioning

Start date: February 2012
Phase: N/A
Study type: Interventional

This research is being done to determine whether transcranial direct current stimulation (tDCS) can improve certain abilities related to cognition, emotion and/or physical functioning in individuals with subcortical brain damage.

NCT ID: NCT00544895 Completed - Clinical trials for Brain Damage, Chronic

Neonatal Estimation Of Brain Damage Risk And Identification of Neuroprotectants

NEOBRAIN
Start date: October 2007
Phase: N/A
Study type: Observational

NEOBRAIN brings together small and medium sized enterprises (SMEs), industry and academic groups devoted to the diagnosis, management, and neuroprotection in newborns with perinatal brain damage. The focus of NEOBRAIN is to identify strategies prevention of brain damage mainly observed in preterm newborns. (Copy from www.neobrain.eu)